ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY

We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade. Spontaneously hypertensive rats, 8 weeks old, were treated with olmesartan,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: H. Yokoyama, D. B. Averill, K. B. Brosnihan, R. D. Smith, E. L. Schiffrin, C. M. Ferrario
Médium: Artigo
Jazyk:Russo
Vydáno: «FIRMA «SILICEA» LLC 2011-08-01
Edice:Российский кардиологический журнал
Témata:
atenolol
cardiac hypertrophy
hypertension
olmesartan
vascular remodelling
On-line přístup:https://russjcardiol.elpub.ru/jour/article/view/1131
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky